BSE Live
Dec 31, 16:01Prev. Close
62.36
Open Price
62.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Balance Sheet of Shukra Pharmaceuticals (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 1.57 | 1.57 | 1.57 | 1.57 | 1.57 | |
| Total Share Capital | 1.57 | 1.57 | 1.57 | 1.57 | 1.57 | |
| Reserves and Surplus | 13.85 | 13.81 | 13.44 | 13.01 | 12.51 | |
| Total Reserves and Surplus | 13.85 | 13.81 | 13.44 | 13.01 | 12.51 | |
| Total Shareholders Funds | 15.41 | 15.38 | 15.01 | 14.58 | 14.07 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 8.05 | 6.06 | 3.58 | 0.04 | 0.04 | |
| Deferred Tax Liabilities [Net] | 3.10 | 2.96 | 2.85 | 2.60 | 2.44 | |
| Other Long Term Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Provisions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Liabilities | 11.15 | 9.02 | 6.43 | 2.64 | 2.48 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade Payables | 6.46 | 3.15 | 1.93 | 1.14 | 0.52 | |
| Other Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Short Term Provisions | 0.52 | 0.85 | 0.73 | 0.58 | 0.21 | |
| Total Current Liabilities | 6.99 | 4.00 | 2.66 | 1.72 | 0.73 | |
| Total Capital And Liabilities | 33.55 | 28.39 | 24.10 | 18.94 | 17.28 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 17.38 | 15.60 | 14.12 | 10.17 | 9.67 | |
| Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Work-In-Progress | 1.66 | 1.66 | 1.66 | 1.64 | 1.68 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 19.04 | 17.27 | 15.78 | 11.81 | 11.36 | |
| Non-Current Investments | 0.05 | 0.05 | 0.05 | 0.04 | 0.04 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Non-Current Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Assets | 19.09 | 17.32 | 15.83 | 11.86 | 11.40 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 1.39 | 0.27 | 0.14 | 0.32 | 0.44 | |
| Trade Receivables | 7.95 | 5.35 | 2.93 | 2.47 | 0.94 | |
| Cash And Cash Equivalents | 0.13 | 0.25 | 0.06 | 0.52 | 1.74 | |
| Short Term Loans And Advances | 4.74 | 4.89 | 4.93 | 3.72 | 2.72 | |
| OtherCurrentAssets | 0.25 | 0.32 | 0.21 | 0.05 | 0.04 | |
| Total Current Assets | 14.45 | 11.07 | 8.27 | 7.08 | 5.88 | |
| Total Assets | 33.55 | 28.39 | 24.10 | 18.94 | 17.28 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 1.96 | 0.06 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 0.25 | 0.00 | 0.00 | 0.00 | 0.00 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | -- | -- | -- | 0.06 | -- | |
| Other Earnings | 0.00 | -- | -- | -- | -- | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | -- | -- | -- | -- | -- | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 0.05 | 0.05 | 0.05 | 0.04 | 0.04 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
24.11.2025
Shukra Pharma Standalone September 2025 Net Sales at Rs 5.88 crore, up 5.8% Y-o-Y
12.06.2025
Shukra Pharma Standalone March 2025 Net Sales at Rs 13.27 crore, up 21.92% Y-o-Y
26.11.2024
Shukra Pharma Standalone September 2024 Net Sales at Rs 5.56 crore, down 77.45% Y-o-Y
13.08.2024
Shukra Pharma Standalone June 2024 Net Sales at Rs 3.18 crore, down 84.24% Y-o-Y